Prion Protein is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
The prion protein (PrP) is a glycosylphosphatidylinositol (GPI)-anchored protein that plays a central role in prion diseases, also known as transmissible spongiform encephalopathies (TSEs). The normal cellular form is termed PrPC, while the disease-causing infectious form is known as PrPSc (scrapie isoform).
¶ Gene and Structure
The prion protein is encoded by the PRNP gene located on chromosome 20p13. The protein consists of:
- An N-terminal signal peptide (1-23 aa)
- A flexible N-terminal domain (23-125 aa) containing octapeptide repeat regions
- A C-terminal globular domain (126-231 aa) containing three α-helices and two β-strands
- A GPI anchor signal at the C-terminus for membrane attachment
Under normal conditions, PrPC is expressed predominantly in the central nervous system, particularly in neurons, astrocytes, and microglia. Its physiological functions include:
- Copper ion binding: PrP can bind copper ions (Cu2+) through its octapeptide repeat region
- Neuroprotection: Exhibits antioxidant and anti-apoptotic properties
- Synaptic function: Involved in synaptic plasticity and neuronal signaling
- Cell adhesion: Facilitates cell-cell interactions in the nervous system
- Copper homeostasis: Participates in copper uptake and distribution
Prion diseases are a group of fatal neurodegenerative disorders characterized by spongiform degeneration, neuronal loss, and gliosis. They include:
- Creutzfeldt-Jakob Disease (CJD): The most common human prion disease
- Variant CJD (vCJD): Linked to consumption of BSE-contaminated beef
- Fatal Familial Insomnia (FFI): Characterized by progressive insomnia and autonomic dysfunction
- Gerstmann-Sträussler-Scheinker syndrome (GSS): Rare hereditary prion disease
- Kuru: Historically associated with ritualistic cannibalism
- Scrapie: Affects sheep and goats
- Bovine Spongiform Encephalopathy (BSE): "Mad cow disease"
- Chronic Wasting Disease (CWD): Affects cervids (deer, elk, moose)
The conversion of normal PrPC to pathogenic PrPSc involves a conformational change in which the protein adopts a β-sheet-rich structure. This process:
- Involves templated misfolding where PrPSc acts as a template
- Results in protein aggregation and formation of amyloid fibrils
- Leads to neurotoxicity through multiple mechanisms
- Can occur sporadically, genetically, or through infection
Current therapeutic strategies targeting the prion protein include:
- Anti-prion compounds: Small molecules that inhibit PrPSc formation
- Immunotherapy: Antibodies targeting PrP for clearance
- Gene silencing: RNA interference approaches to reduce PrP expression
- Stabilizing compounds: Agents that stabilize the normal PrPC conformation